Therapeutic Trial of Interferon‐&ggr; in Patients with Epidemic Kaposi's Sarcoma
作者:
Robert Krigel,
Chrystia Odajnyk,
Linda Laubenstein,
Richard Ostreicher,
James Wernz,
Jan Vilček,
Pablo Rubinstein,
Alvin Friedman‐Kien,
期刊:
Journal of Biological Response Modifiers
(OVID Available online 1985)
卷期:
Volume 4,
issue 4
页码: 358-364
ISSN:0732-6580
年代: 1985
出版商: OVID
关键词: Acquired immune deficiency syndrome;Biologic response modifier;Epidemic Kaposi's sarcoma;Interferon;Interferon‐&ggr;.
数据来源: OVID
摘要:
Summary:An epidemic form of Kaposi's sarcoma associated with the acquired immune deficiency syndrome has been recently described. Seven homosexual men with biopsy‐documented epidemic Kaposi's sarcoma were treated with a human interferon‐&ggr; preparation. All patients had generalized disease. Only one patient had received prior chemotherapy, and one other patient had recovered from a prior opportunistic infection. Interferon‐&ggr; was administered in a dose of 500,000 U intramuscularly daily, with two 10‐day induction courses, separated by a 2‐week medication‐free period. This was followed by maintenance therapy in the same dose twice weekly. Toxicities consisted of a flu‐like illness with high fevers, shaking chills, myalgias, and arthralgias. There were no complete or partial responses. All patients exhibited disease progression, with a rapid progression of previously stable disease necessitating discontinuation of therapy in three patients. We conclude that low doses of this human interferon‐&ggr; preparation are ineffective in epidemic Kaposi's sarcoma.
点击下载:
PDF
(3069KB)
返 回